FOR REFERENCE ONLY – NOT FOR EXECUTION – UPDATED 3.25.2022

Paperwork Reduction Act Notice.

OMB Approval No. 1505-0267

Expiration Date: June 30, 2022

The information collected will be used for the U.S. Government to process requests for support. The estimated burden associated with this 

collection of information is 8 hours for the letter agreement. Comments concerning the accuracy of this burden estimate and suggestions for 

reducing this burden should be directed to the Office of Privacy, Transparency and Records, Department of the Treasury, 1500 Pennsylvania 

Ave., N.W., Washington, D.C. 20220. DO NOT send the form to this address. An agency may not conduct or sponsor, and a person is not 

required to respond to, a collection of information unless it displays a valid control number assigned by OMB.

(ECIP Mutual Institutions/Subchapter S Corporations

Subordinated Debt)

UNITED STATES DEPARTMENT OF THE TREASURY

1500 PENNSYLVANIA AVENUE, NW

WASHINGTON, D.C. 20220

Dear Ladies and Gentlemen:

The company set forth on the signature page hereto (the “Recipient”) intends to issue in a 

private placement the subordinated debentures set forth on Schedule A hereto (the “Subordinated 

Debt”) and the United States Department of the Treasury (the “Investor”) intends to purchase 

from the Recipient the Subordinated Debt, pursuant to the Emergency Capital Investment 

Program.

The purpose of this letter agreement is to confirm the terms and conditions of the 

purchase by the Investor of the Subordinated Debt. Except to the extent supplemented or 

superseded by the terms set forth herein or in the Schedules hereto, the provisions contained in 

the Securities Purchase Agreement – Standard Terms attached hereto as Exhibit A (the 

“Securities Purchase Agreement”) are incorporated by reference herein. Terms that are defined 

in the Securities Purchase Agreement are used in this letter agreement as so defined. In the event 

of any inconsistency between this letter agreement and the Securities Purchase Agreement, the 

terms of this letter agreement shall govern.

Each of the Recipient and the Investor hereby confirms its agreement with the other party 

with respect to the issuance by the Recipient of the Subordinated Debt and the purchase by the 

Investor of the Subordinated Debt pursuant to this letter agreement and the Securities Purchase 

Agreement on the terms specified on Schedule A hereto.

This letter agreement (including the Schedules hereto), the Securities Purchase 

Agreement (including the Annexes thereto) and the Disclosure Schedules (as defined in the 

Securities Purchase Agreement) constitute the entire agreement, and supersede all other prior 

agreements, understandings, representations and warranties, both written and oral, between the 

parties, with respect to the subject matter hereof. This letter agreement constitutes the “Letter 

Agreement” referred to in the Securities Purchase Agreement.

This letter agreement may be executed in any number of separate counterparts, each such 

counterpart being deemed to be an original instrument, and all such counterparts will together 

constitute the same agreement. In addition, this letter agreement may be executed by electronic 

signature in accordance with the E-SIGN Act of 2000. Executed signature pages to this letter 

agreement may be delivered by facsimile or electronic mail (including pdf) and such facsimiles 

or electronic copies will be deemed as sufficient as if actual signature pages had been delivered.

* * *
FOR REFERENCE ONLY – NOT FOR EXECUTION – UPDATED 3.25.2022

In witness whereof, this letter agreement has been duly executed and delivered by the 

duly authorized representatives of the parties hereto as of the date written below.

UNITED STATES DEPARTMENT OF THE 

TREASURY

By: 

Name:

Title:

RECIPIENT: 

By: 

Name:

Title:

Date: 
FOR REFERENCE ONLY – NOT FOR EXECUTION – UPDATED 3.25.2022

EXHIBIT A

SECURITIES PURCHASE AGREEMENT
FOR REFERENCE ONLY – NOT FOR EXECUTION – UPDATED 3.25.2022

SCHEDULE A

ADDITIONAL TERMS AND CONDITIONS

Recipient Information:

Name of the Recipient:

Corporate or Other Organizational Form of Recipient:

Mutual Institution or Subchapter S Corporation:

Holding Company or Insured Depository Institution:

Jurisdiction of Organization of Recipient:

Appropriate Federal Banking Agency of Recipient:

Notice Information:

Terms of the Purchase:

Original Aggregate Principal 

Amount of Subordinated Debt in 

the Form of Annex A Purchased:

$______________

Purchase Price: $______________

Denomination Amount: $1,000.00

Maximum Aggregate Principal 

Amount:

Not to exceed [7.5 percent][15 percent][22.5 

percent] of the Recipient’s Total Assets.1

1 The general investment limit per Recipient is $250,000,000. In addition, the following limitations apply to the 

aggregate principal amount of Subordinated Debt a Recipient may issue, based on a Recipient’s Total Assets 

(defined below): 

• Recipients with more than $2 billion in Total Assets: the aggregate principal amount of Subordinated 

Debt issued may not exceed 7.5% of Total Assets;

• Recipients with at least $500 million and not more than $2 billion in Total Assets: the aggregate 

principal amount of Subordinated Debt issued may not exceed 15% of Total Assets; and 

• Recipients with less than $500 million in Total Assets: the aggregate principal amount of Subordinated 

Debt issued may not exceed 22.5% of Total Assets. 

“Total assets” means (i) for recipients that file reporting Form FR Y-9C, the total consolidated assets as reported in 

Schedule HC of the FR Y-9C, (ii) for recipients that file a Consolidated Report of Condition and Income (“Call 

Report”), the total assets as reported on Schedule RC of the Call Report, and (iii) for Recipients that file on reporting 

Form FR Y-9SP or FR Y-9LP but not FR Y-9C the higher of the (1) total assets reported in Schedule SC of the FR 
FOR REFERENCE ONLY – NOT FOR EXECUTION – UPDATED 3.25.2022

Maturity: [15][30] years

Interest Rate: No interest accrues, nor will any interest be due for the 

first 24 months following the Closing Date. Interest will 

begin to accrue on the two-year anniversary of the 

Closing Date. The first quarterly payment will be due on 

the first interest payment date after that date. From the 

two-year anniversary of the Closing Date, interest 

payments will reflect the Recipient’s Qualified Lending 

compared to the Baseline in accordance with the terms of 

the Securities Purchase Agreement.

Interest Payment Dates: Quarterly, in arrears, on March 15, June 15, September 

15 and December 15 of each year.

Closing (by electronic exchange of documents):

Time of Closing:

Date of Closing:

Y-9SP or Schedule PC of the FR Y-9LP, as applicable and (2) total assets reported in the Call Report of such 

recipient’s primary insured depository institution subsidiary.
FOR REFERENCE ONLY – NOT FOR EXECUTION – UPDATED 3.25.2022

Wire Information for Closing: ABA Number:

Bank:

Account Name:

Account Number:

Beneficiary:

Contact for Confirmation of Wire Information: 2

Address for Delivery of Subordinated Debt:

[Address]

[Address]

[Address]

Attention: [•]

Email tracking number for such mailing to: [•]

2

Include the name, title and contact information (telephone number and email address). The contact must be a 

person different from the officer executing the Letter Agreement.
FOR REFERENCE ONLY – NOT FOR EXECUTION – UPDATED 3.25.2022

SCHEDULE B

CAPITALIZATION

If the Recipient is a Mutual Institution:

Capitalization Date:

Equity:

Type of Interest:

Par Value:

Total Authorized:

Outstanding:

Subject to Warrants, Options, Convertible

Securities, etc.:

Reserved for Benefit Plans and Other Issuances:

Remaining Authorized but Unissued:

Subordinated Debt:

Type:

Existing Parity Subordinated Debt:

Trust Preferred Outstanding:

Amount Outstanding:

Holders of 5% or more of Equity Primary Address

Potential Sales

Describe any commitments to authorize, issue or sell any Equity interests (other than in 

connection with the ordinary course issuance of shares to new members):

If none, please so indicate by checking the box: ☐.
FOR REFERENCE ONLY – NOT FOR EXECUTION – UPDATED 3.25.2022

If the Recipient is a Bank Holding Company or a Savings and Loan Holding Company:

A list of each IDI Subsidiary noting the percentage of each IDI Subsidiary’s issued and 

outstanding capital stock that is owned by the Recipient:

If the Recipient is a Subchapter S Corporation:

Capitalization Date:

Equity:

Par Value:

Total Authorized:

Outstanding:

Subject to Warrants, Options, Convertible

Securities, etc.:

Reserved for Benefit Plans and Other Issuances:

Remaining Authorized but Unissued:

Subordinated Debt:

Type:

Existing Parity Subordinated Debt:

Trust Preferred Outstanding:

Amount Outstanding:

Holders of 5% or more of Equity Primary Address

Potential Sales

Describe any commitments to authorize, issue or sell any Equity interests:

If none, please so indicate by checking the box: ☐
FOR REFERENCE ONLY – NOT FOR EXECUTION – UPDATED 3.25.2022

If the Recipient is a Bank Holding Company or a Savings and Loan Holding Company:

A list of each IDI Subsidiary noting the percentage of each IDI Subsidiary’s issued and 

outstanding capital stock that is owned by the Recipient:
FOR REFERENCE ONLY – NOT FOR EXECUTION – UPDATED 3.25.2022

SCHEDULE C

MATERIAL ADVERSE EFFECT

List any exceptions to the representation and warranty in Section 3.1(g) of the Securities 

Purchase Agreement – Standard Terms.

If none, please so indicate by checking the box: ☐
FOR REFERENCE ONLY – NOT FOR EXECUTION – UPDATED 3.25.2022

SCHEDULE D

LITIGATION

List any exceptions to the representation and warranty in Section 3.1(l) of the Securities 

Purchase Agreement – Standard Terms.

If none, please so indicate by checking the box: ☐
FOR REFERENCE ONLY – NOT FOR EXECUTION – UPDATED 3.25.2022

SCHEDULE E

COMPLIANCE WITH LAWS

List any exceptions to the representation and warranty in the second sentence of Section 3.1(m) 

of the Securities Purchase Agreement – Standard Terms.

If none, please so indicate by checking the box: ☐

List any exceptions to the representation and warranty in the last sentence of Section 3.1(m) of 

the Securities Purchase Agreement – Standard Terms.

If none, please so indicate by checking the box: ☐
FOR REFERENCE ONLY – NOT FOR EXECUTION – UPDATED 3.25.2022

SCHEDULE F

REGULATORY AGREEMENTS

List any exceptions to the representation and warranty in Section 3.1(s) of the Securities 

Purchase Agreement – Standard Terms.

If none, please so indicate by checking the box: ☐
FOR REFERENCE ONLY – NOT FOR EXECUTION – UPDATED 3.25.2022

SCHEDULE G

RELATED PARTY TRANSACTIONS

List any exceptions to the representation and warranty in Section 3.1(x) of the Securities 

Purchase Agreement – Standard Terms.

If none, please so indicate by checking the box: ☐
FOR REFERENCE ONLY – NOT FOR EXECUTION – UPDATED 3.25.2022

SCHEDULE H

OTHER EXCEPTIONS

List any exceptions to the representations and warranties in the Securities Purchase Agreement –

Standard Terms not covered in Schedules C through G above and, for each listed exception, 

identify the applicable representation and warranty in Section 3.1 by the applicable subsection.

If none, please so indicate by checking the box: ☐